

EXR Makes Bullish Cross Above Critical Moving Average
Continue reading at Nasdaq


Continue reading at Nasdaq


Bullish Two Hundred Day Moving Average Cross - OC
Continue reading at Nasdaq


Booz Allen Hamilton Holding Named Top Dividend Stock With Insider Buying and 2.84% Yield (BAH)
Continue reading at Nasdaq


DFAR Crosses Above Key Moving Average Level
Continue reading at Nasdaq


Nike, Accused of Bias Against White Workers, Is Under Federal Investigation
Continue reading at The New York Times


Dollar Gains as US Government Shutdown Ends and Stocks Fall
Continue reading at Nasdaq


Notable Two Hundred Day Moving Average Cross - BULZ
Continue reading at Nasdaq


Watsco Breaks Above 200-Day Moving Average - Bullish for WSO
Continue reading at Nasdaq


Notable Two Hundred Day Moving Average Cross - TSLL
Continue reading at Nasdaq


QQQI Makes Notable Cross Below Critical Moving Average
Continue reading at Nasdaq


UGI Corp. Profit Retreats In Q4
Continue reading at Nasdaq


Snap Q4 Profit Surges, Revenue Up 10%
Continue reading at Nasdaq


Black Hills Corp Q4 Profit Advances
Continue reading at Nasdaq


This High-Growth Coffee Stock is Massively Mispriced for the Next Decade
Continue reading at Nasdaq


Should You Buy D-Wave Stock Before Its Next Breakout?
Continue reading at Nasdaq


Madison Asset Initiates MSA Safety Position
Continue reading at Nasdaq


Oscar Health Becomes Oversold (OSCR)
Continue reading at Nasdaq


Oversold Conditions For Caris Life Sciences (CAI)
Continue reading at Nasdaq


iShares China Large-Cap Breaks Below 200-Day Moving Average - Notable for FXI
Continue reading at Nasdaq


Notable Two Hundred Day Moving Average Cross - RDNT
Continue reading at Nasdaq


FORTY Crosses Below Key Moving Average Level
Continue reading at Nasdaq


2 No-Brainer Dividend Stocks to Buy Right Now
Continue reading at Nasdaq


Tom Gardner's 2026 Outlook: Volatility, Government Scrutiny, and Two AI-Adjacent Stocks
Continue reading at Nasdaq


Continue reading at Nasdaq


MetLife Inc. Reveals Drop In Q4 Profit
Continue reading at Nasdaq


Veracyte is Now Oversold (VCYT)
Continue reading at Nasdaq